Logo image of NUWE

NUWELLIS INC (NUWE) Stock Fundamental Analysis

USA - NASDAQ:NUWE - US67113Y7022 - Common Stock

2.67 USD
-0.2 (-6.97%)
Last: 11/10/2025, 1:57:08 PM
Fundamental Rating

2

Overall NUWE gets a fundamental rating of 2 out of 10. We evaluated NUWE against 189 industry peers in the Health Care Equipment & Supplies industry. NUWE has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, NUWE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NUWE has reported negative net income.
NUWE had a negative operating cash flow in the past year.
NUWE had negative earnings in each of the past 5 years.
In the past 5 years NUWE always reported negative operating cash flow.
NUWE Yearly Net Income VS EBIT VS OCF VS FCFNUWE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

The Return On Assets of NUWE (-159.51%) is worse than 88.89% of its industry peers.
Industry RankSector Rank
ROA -159.51%
ROE N/A
ROIC N/A
ROA(3y)-132.73%
ROA(5y)-110.12%
ROE(3y)-328.31%
ROE(5y)-233.66%
ROIC(3y)N/A
ROIC(5y)N/A
NUWE Yearly ROA, ROE, ROICNUWE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

NUWE's Gross Margin of 60.54% is fine compared to the rest of the industry. NUWE outperforms 61.90% of its industry peers.
NUWE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for NUWE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y4.66%
NUWE Yearly Profit, Operating, Gross MarginsNUWE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

2

2. Health

2.1 Basic Checks

NUWE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NUWE has been increased compared to 1 year ago.
The number of shares outstanding for NUWE has been increased compared to 5 years ago.
NUWE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NUWE Yearly Shares OutstandingNUWE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K 80K 100K
NUWE Yearly Total Debt VS Total AssetsNUWE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

NUWE has an Altman-Z score of -49.80. This is a bad value and indicates that NUWE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -49.80, NUWE is doing worse than 93.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -49.8
ROIC/WACCN/A
WACC8.75%
NUWE Yearly LT Debt VS Equity VS FCFNUWE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 2.16 indicates that NUWE has no problem at all paying its short term obligations.
NUWE's Current ratio of 2.16 is in line compared to the rest of the industry. NUWE outperforms 40.74% of its industry peers.
NUWE has a Quick Ratio of 1.64. This is a normal value and indicates that NUWE is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.64, NUWE perfoms like the industry average, outperforming 44.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.64
NUWE Yearly Current Assets VS Current LiabilitesNUWE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for NUWE have decreased strongly by -71.92% in the last year.
NUWE shows a decrease in Revenue. In the last year, the revenue decreased by -7.70%.
NUWE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.67% yearly.
EPS 1Y (TTM)-71.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-223.32%
Revenue 1Y (TTM)-7.7%
Revenue growth 3Y3.34%
Revenue growth 5Y9.67%
Sales Q2Q%-21.38%

3.2 Future

NUWE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.99% yearly.
NUWE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.06% yearly.
EPS Next Y99.74%
EPS Next 2Y41.38%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year2.8%
Revenue Next 2Y24.85%
Revenue Next 3Y35.82%
Revenue Next 5Y45.06%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NUWE Yearly Revenue VS EstimatesNUWE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M
NUWE Yearly EPS VS EstimatesNUWE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -200M -400M -600M -800M -1B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NUWE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NUWE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUWE Price Earnings VS Forward Price EarningsNUWE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUWE Per share dataNUWE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600

4.3 Compensation for Growth

A more expensive valuation may be justified as NUWE's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.38%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NUWE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NUWELLIS INC

NASDAQ:NUWE (11/10/2025, 1:57:08 PM)

2.67

-0.2 (-6.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners2.03%
Inst Owner Change-0.74%
Ins Owners0.02%
Ins Owner Change99.63%
Market Cap2.40M
Revenue(TTM)8.32M
Net Income(TTM)-14.68M
Analysts82.86
Price TargetN/A
Short Float %4.46%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-20.48%
Min Revenue beat(2)-23.13%
Max Revenue beat(2)-17.82%
Revenue beat(4)0
Avg Revenue beat(4)-12.51%
Min Revenue beat(4)-23.13%
Max Revenue beat(4)-1.58%
Revenue beat(8)2
Avg Revenue beat(8)-6.27%
Revenue beat(12)3
Avg Revenue beat(12)-7.31%
Revenue beat(16)5
Avg Revenue beat(16)-7.63%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-769.02
EYN/A
EPS(NY)-0.94
Fwd EYN/A
FCF(TTM)-9.58
FCFYN/A
OCF(TTM)-9.56
OCFYN/A
SpS9.24
BVpS-9.95
TBVpS-9.95
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -159.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.54%
FCFM N/A
ROA(3y)-132.73%
ROA(5y)-110.12%
ROE(3y)-328.31%
ROE(5y)-233.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y4.66%
F-Score5
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.9%
Cap/Sales 0.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.16
Quick Ratio 1.64
Altman-Z -49.8
F-Score5
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)40.1%
Cap/Depr(5y)48.83%
Cap/Sales(3y)1.63%
Cap/Sales(5y)2.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-223.32%
EPS Next Y99.74%
EPS Next 2Y41.38%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.7%
Revenue growth 3Y3.34%
Revenue growth 5Y9.67%
Sales Q2Q%-21.38%
Revenue Next Year2.8%
Revenue Next 2Y24.85%
Revenue Next 3Y35.82%
Revenue Next 5Y45.06%
EBIT growth 1Y28.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.48%
OCF growth 3YN/A
OCF growth 5YN/A

NUWELLIS INC / NUWE FAQ

Can you provide the ChartMill fundamental rating for NUWELLIS INC?

ChartMill assigns a fundamental rating of 2 / 10 to NUWE.


What is the valuation status for NUWE stock?

ChartMill assigns a valuation rating of 1 / 10 to NUWELLIS INC (NUWE). This can be considered as Overvalued.


How profitable is NUWELLIS INC (NUWE) stock?

NUWELLIS INC (NUWE) has a profitability rating of 1 / 10.


Can you provide the financial health for NUWE stock?

The financial health rating of NUWELLIS INC (NUWE) is 2 / 10.